Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrom.

× No keyword cloud information.

6 in total

1. On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use.

Authors: S Björkman; H Sievertsson
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1977-06 Impact factor: 3.000

Review 2. Concepts for biologically active peptides.

Authors: Abba J Kastin; Weihong Pan
Journal: Curr Pharm Des Date: 2010-10 Impact factor: 3.116

3. Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy.

Authors: T Caraceni; E A Parati; F Girotti; I Celano; C Frigerio; D Cocchi; E E Müller
Journal: Psychopharmacology (Berl) Date: 1979-06-21 Impact factor: 4.530

4. Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

Authors: A Barbeau; M Roy; A J Kastin
Journal: Can Med Assoc J Date: 1976-01-24 Impact factor: 8.262

5. Comparison of thyrotropin-releasing hormone with melanocyte-stimulating-hormone-release-inhibiting factor as pentobarbital antagonists in monkeys.

Authors: T J Crowley; M Hydinger
Journal: Psychopharmacology (Berl) Date: 1977-07-18 Impact factor: 4.530

6. Mass spectrometric quantification of MIF-1 in mouse brain by multiple reaction monitoring.

Authors: Indu Kheterpal; Abba J Kastin; Sahana Mollah; Chuanhui Yu; Hung Hsuchou; Weihong Pan
Journal: Peptides Date: 2009-04-11 Impact factor: 3.750

6 in total